Carbapenem-Resistant P. aeruginosa from Medical Tourism

Some U.S. residents obtaining surgical procedures in Mexico are returning infected with metallo-ß-lactamase–producing carbapenem-resistant Pseudomonas aeruginosa.

Carbapenem-resistant organisms including Pseudomonas aeruginosa (CRPA), Acinetobacter spp., and Enterobacteriaceae are an emerging cause of infections that are difficult to treat and can spread within healthcare facilities. These organisms have been relatively rare in the U.S., but from September 18 to November 19, 2018, the CDC received 31 reports of Verona integron-encoded metallo-ß-lactamase–producing carbapenem-resistant P. aeruginosa (VIM-CRPA) through the Antibiotic Resistance Laboratory Network. Six of these reports involved U.S. patients who had recently undergone invasive medical procedures in Mexico.

At that point, an Epi-X alert was issued by the CDC, revealing a total of 12 such cases identified in seven states from samples taken…

Reviewing Author

Stephen G. Baum, MD

Disclosures

Consultant/Advisory BoardClinical Infectious Diseases

RoyaltiesUpToDate

Editorial BoardsMedical Letter

Stephen G. Baum, MD

Disclosures

Consultant/Advisory BoardClinical Infectious Diseases

RoyaltiesUpToDate

Editorial BoardsMedical Letter

Carbapenem-Resistant P. aeruginosa from Medical Tourism

Topics

Reviewing Author